bpc-157 clinical research – Peptide bpc-157 human clinical trials evidence
Description
By age 40, most people with Down syndrome have significant levels of betaamyloid plaques and tau tangles in their brains
More fat means more target vasculature, which means more binding sites for FTPP
Im opting out of the second injection
D., & Theodore, B
Not for human consumption, medical treatment, diagnostic purposes, or veterinary use
Can BPC-157 be used to treat specific conditions
